Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GFAP at 50
Albee Messing, Michael Brenner
ASN NEURO (2020) Vol. 12, pp. 175909142094968-175909142094968
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Ahmed Abdelhak, Matteo Foschi, Samir Abu‐Rumeileh, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 3, pp. 158-172
Open Access | Times Cited: 475
Behaviorally consequential astrocytic regulation of neural circuits
Jun Nagai, Xinzhu Yu, Thomas Papouin, et al.
Neuron (2020) Vol. 109, Iss. 4, pp. 576-596
Open Access | Times Cited: 230
Regulation of GFAP Expression
Michael Brenner, Albee Messing
ASN NEURO (2021) Vol. 13, pp. 175909142098120-175909142098120
Open Access | Times Cited: 79
Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses
Edward Needham, Alexander Ren, Richard Digby, et al.
Brain (2022) Vol. 145, Iss. 11, pp. 4097-4107
Open Access | Times Cited: 66
Molecular Mechanisms Underlying Neuroinflammation Elicited by Occupational Injuries and Toxicants
Dhruba Pathak, Krishnan Sriram
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2272-2272
Open Access | Times Cited: 42
Heterogeneity analysis of astrocytes following spinal cord injury at single‐cell resolution
Jinxing Hou, Huiru Bi, Qiting Ge, et al.
The FASEB Journal (2022) Vol. 36, Iss. 8
Closed Access | Times Cited: 40
Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease
Yara Yakoub, Nicholas J. Ashton, Cherie Strikwerda‐Brown, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 12, pp. 5620-5631
Open Access | Times Cited: 33
GFAP-isoforms in the nervous system: Understanding the need for diversity
A. Reus, Onur Basak, Werner Dykstra, et al.
Current Opinion in Cell Biology (2024) Vol. 87, pp. 102340-102340
Open Access | Times Cited: 10
Blood-brain barrier biomarkers
Juan F. Zapata-Acevedo, Alejandra Mantilla-Galindo, Karina Vargas-Sánchez, et al.
Advances in clinical chemistry (2024), pp. 1-88
Closed Access | Times Cited: 10
Cognitive Healthy Aging in Mice: Boosting Memory by an Ergothioneine-Rich Hericium erinaceus Primordium Extract
E. Roda, Fabrizio De Luca, Daniela Ratto, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 196-196
Open Access | Times Cited: 22
Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP
Konstantinos Chiotis, Charlotte Johansson, E. Rodriguez-Vieitez, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 18
Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment
Tracy L. Hagemann, Berit Powers, Ni‐Hsuan Lin, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 620
Open Access | Times Cited: 37
Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis
Georgios Katsipis, Elena E. Tzekaki, Magda Tsolaki, et al.
Journal of Neuroimmunology (2021) Vol. 361, pp. 577744-577744
Closed Access | Times Cited: 36
GFAP Alternative Splicing and the Relevance for Disease – A Focus on Diffuse Gliomas
Jessy V. van Asperen, Pierre A. Robe, Elly M. Hol
ASN NEURO (2022) Vol. 14, pp. 175909142211020-175909142211020
Open Access | Times Cited: 27
Vascular risk factors and astrocytic marker for the glymphatic system activity
Yi‐Chia Wei, Chih‐Chin Heather Hsu, Wen‐Yi Huang, et al.
La radiologia medica (2023) Vol. 128, Iss. 9, pp. 1148-1161
Open Access | Times Cited: 15
Glial fibrillary acidic protein in Alzheimer’s disease: a narrative review
Florine Leipp, Jérôme Vialaret, Pablo Mohaupt, et al.
Brain Communications (2024) Vol. 6, Iss. 6
Open Access | Times Cited: 6
Glial fibrillary acidic protein is pathologically modified in Alexander disease
Ni‐Hsuan Lin, Wan-Syuan Jian, Natasha T. Snider, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 7, pp. 107402-107402
Open Access | Times Cited: 5
Alexander disease: models, mechanisms, and medicine
Tracy L. Hagemann
Current Opinion in Neurobiology (2021) Vol. 72, pp. 140-147
Open Access | Times Cited: 32
Radial Glial Cells: New Views on Old Questions
Jon I. Arellano, Yury M. Morozov, Nicola Micali, et al.
Neurochemical Research (2021) Vol. 46, Iss. 10, pp. 2512-2524
Open Access | Times Cited: 30
Metrnl regulates cognitive dysfunction and hippocampal BDNF levels in D-galactose-induced aging mice
Hong Chen, Zhi Wang, Si‐Li Zheng, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 4, pp. 741-751
Open Access | Times Cited: 22
The redox-responsive roles of intermediate filaments in cellular stress detection, integration and mitigation
Dolores Pérez‐Sala, Roy A. Quinlan
Current Opinion in Cell Biology (2023) Vol. 86, pp. 102283-102283
Open Access | Times Cited: 11
The GFAP proteoform puzzle: How to advance GFAP as a fluid biomarker in neurological diseases
Dea Gogishvili, Madison I. J. Honey, Inge M.W. Verberk, et al.
Journal of Neurochemistry (2024)
Open Access | Times Cited: 4
MRI features and evolution of autoimmune glial fibrillary acidic protein astrocytopathy: A retrospective cross-sectional and longitudinal study
Huiting Liao, Qianlan Chen, Zhang Min, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 58, pp. 103512-103512
Closed Access | Times Cited: 18
Alexander disease GFAP R239C mutant shows increased susceptibility to lipoxidation and elicits mitochondrial dysfunction and oxidative stress
Álvaro Viedma-Poyatos, Patricia González-Jiménez, Marı́a A. Pajares, et al.
Redox Biology (2022) Vol. 55, pp. 102415-102415
Open Access | Times Cited: 18
GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
Roxana Radu, George E. D. Petrescu, Radu Mircea Gorgan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top